When shared with the patient, the AGP results were found to be an effective basis for education, helping achieve better understanding of glycemic variability and increasing involvement in diabetes self-management.64 Most recently, use of remotely monitored CGM data as a component of a comprehensive telemedicine program showed statistically significant HbA1c reductions (P < 0.001) in a cohort to 594 T2D adults treated with less intensive insulin therapy or noninsulin medications.15 The gene discussed is INS; the disease is type 2 diabetes mellitus.